Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2021  |  Volume : 9  |  Issue : 2  |  Page : 89-94

Chemotherapy-induced ovarian toxicity in female cancer patients from selected Nigerian Tertiary Health Care


Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria

Correspondence Address:
Mr. John Abiodun Obadipe
Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/njecp.njecp_3_21

Rights and Permissions

Introduction: Preservation of ovarian function and fertility has become one of the major qualities of life issues for patients of reproductive age undergoing chemotherapy. Thus, monitoring ovarian reserve in the course of chemotherapy is of utmost importance for prediction of patients' reproductive life span. Aim: The study investigated the ovarian toxicity of chemotherapy in female cancer patients in selected Nigerian tertiary hospitals. Materials and Methods: One hundred and sixty participants comprised hundred radiotherapy-naive female cancer patients aged 18–72 years across all stages and sixty age-matched healthy volunteers (control) randomly selected from three medical centers in South West Nigeria. Patients' demographics and cycle of chemotherapy were obtained using questionnaire. Three milliliters of blood was collected intravenously from the participants before chemotherapy and a week after chemotherapy. Anti-Müllerian hormone (AMH) and inhibin B hormone levels in the serum samples were quantified by enzyme-linked immunosorbent assay. Tukey's honestly significant difference one-way analysis of variance was employed to test for the significant difference, with the level of significance considered at P < 0.05. Results: The findings of the study revealed a significant decrease (P = 0.000) in AMH and inhibin B levels of the participants before and after receiving chemotherapy as compared to that of control. In the same way, there was a significant decrease in postchemotherapy AMH (P = 0.001) and inhibin B levels (P = 0.004) as compared to that of prechemotherapy. Conclusion: Decreased postchemotherapy ovarian reserve in cancer patients confirmed chemotherapy-induced ovarian toxicity.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed756    
    Printed6    
    Emailed0    
    PDF Downloaded68    
    Comments [Add]    

Recommend this journal